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E-mail address: asdahl@fmrib.ox.ac.uk (A.R. SegerdWe identiﬁed a patient with severe inherited erythromelalgia secondary to an L858F mutation in the
voltage-gated sodium channel Nav1.7. The patient reported severe ongoing foot pain, which was exqui-
sitely sensitive to limb cooling. We conﬁrmed this heat hypersensitivity using quantitative sensory
testing. Additionally, we employed a novel perfusion imaging technique in a simple block design to assess
her baseline erythromelalgia pain vs cooling relief. Robust activations of key pain, pain-affect, and
reward-related centres were observed. This combined approach allowed us to conﬁrm the presence of
a temperature-sensitive channelopathy of peripheral neurons and to investigate the neural correlates
of tonic neuropathic pain and relief in a single subject.
 2012 Published by Elsevier B.V. on behalf of International Association for the Study of Pain.1. Introduction
Erythromelalgia is characterised by severe burning pain associ-
ated with reddening of the extremities [27,37]. Inherited erythro-
melalgia (IEM) has been shown to be due to gain-of-function
mutations in the SCN9A gene encoding the voltage-gated sodium
channel Nav1.7 [13,16,40] that is selectively expressed in sensory
and autonomic neurons [34]. Sufferers of this disease often report
pain ‘‘attacks,’’ which are triggered by mild warming stimuli (eg,
wearing socks or exercise). Many patients report that cooling of
the affected limb can ameliorate pain [16,37], and this correlates
with the biophysical ﬁnding that the hyperpolarizing shift in acti-
vation produced by IEM mutations can be partially normalized by
cooling [17]. The strong temperature dependence of this condition
provides a means to link a molecular lesion causing aberrant
peripheral nociceptor function and the resulting higher cortical
processing related to ongoing pain perception.alf of International Association for
on of Anaesthetics, Nufﬁeld
ctional Magnetic Resonance
xford, Oxfordshire OX3 9DU,
ahl).Currently, our understanding of the neural correlates of chronic,
ongoing pain is minimal. A key reason for this is due to an inability
to safely and noninvasively image neural activity across a whole
brain during periods of tonic pain. Previously, chronic pain was
investigated with the powerful but very invasive and expensive
technique positron emission tomography [6,10,12,21,22,25,35].
Excitingly, an emerging body of work suggests that the noninva-
sive neuroimaging technique arterial spin labelling (ASL) is opti-
mally suited to investigate these aspects of the pain experience
without the need for radioactive tracers or multiple repeat scans.
ASL is a quantitative perfusion imaging technique that measures
changes in neural activity based on related ﬂuctuations in the local
cerebral blood ﬂow (CBF). Because ASL isminimally affected by low-
frequency drift that undermines blood-oxygen-level-dependent
(BOLD) functional magnetic resonance imaging (fMRI) in a tonic
stimulus paradigm, it is possible to image changes in cortical activ-
ity that unfold over long (ie, on the minute timescale) periods of
time [1,38]. To date, ASL pain studies are few. However, recent
investigations by Owen [29,30] and Howard [19] provide prelimin-
ary evidence that ASL is well suited to observe changes in brain
activity related to different ongoing pain states [19,29,30].
The aim of the current investigation was to interrogate a rare
inherited neuropathic pain condition using a composite experi-
mental procedure that included molecular genetics, quantitativethe Study of Pain. Open access under CC BY license.
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this molecule-to-man approach is to link the unique
neurophysiological properties associated with a point-mutation
in the sodium channel NaV1.7 to higher cortical pain processing.
2. Methods
A single erythromelalgia sufferer (female, right handed, age
32 years) participated in this study. The subject was recruited as
part of the Pain in Neuropathy Study (National Research Ethics
Committee UK no. 10/H07056/35) and complied with experimen-
tal studies in humans (Declaration of Helsinki). The subject gave
her permission for clinical details to be written up as a case report.
2.1. Assessment of genotype: molecular genetic assessment
Following informed consent, all 26 coding exons of the SCN9A
gene were sequenced (Department of Gastroenterology, Radboud
University Nijmegen Medical Center, The Netherlands).
2.2. Quantitative sensory testing and experimental pain paradigm
A full quantitative sensory testing (QST) protocol was con-
ducted in accordance with the German Research Network on Neu-
ropathic Pain [32]. The standardised protocol measures 13
psychophysical parameters through 7 tests, which may be divided
into the following groups: (1) Thermal testing for detection and
painful thresholds for cold, warm, and paradoxical heat sensations;
(2) Detection thresholds of touch and vibration; (3) Mechanical
pain sensitivity including stimulus response functions for pinprick
sensitivity, summation of pain following repetitive stimulation,
and dynamic mechanical allodynia.
Results from each parameter, irrespective of units of measure-
ment for each test, can be graphically represented for both the con-
trol and test sites as a QST proﬁle. Proﬁles for each site can be
compared with the bank of control data by z-transformation of
each parameter by the equation [11]:
z-score ¼ ðXsingle patientÞ MeancontrolsÞ=SDcontrols
The resultant z-transformed proﬁle represents all parameters as
standard normal distributions where the mean equals zero. As pro-
posed by Rolke et al. (2006), the algebraic sign of the score for eachFig. 1. Graphic representation of the erythromelalgia psychophysical paradigm. For clari
over the subject’s feet: ‘‘BASE’’ (mean temperature = 35.5F, SE = 0.72; light gray) vs ‘‘c
arterial spin labelling scan paradigm used. A 10-minute resting-state (RSN) was acqui
erythromelalgia-associated pain (BASE, light blue) vs pain-relief (cool, dark gray) wer
3 minutes. Two separate scan sessions were acquired for this subject. Black bars show wparameter was adjusted to represent the patient’s sensitivity [32].
Positive z-values indicate a gain of function, where the patient is
hypersensitive to the test stimulus relative to controls. Conversely,
negative z-values indicate a loss of function where the patient is
less sensitive.
A 95% conﬁdence interval (CI) of a standard normal distribution
is used to deﬁne the control population, represented in Fig. 3 by the
grey area. This CI is established by:
95% CI ¼Meancontrols  1:96 SDcontrols
A graphic representation of the experimental stimulus para-
digm employed is displayed in Fig. 1. A motorized water perfusion
system was made in-house at the Centre for Functional Magnetic
Resonance Imaging of the Brain (FMRIB) by modifying parts and
machinery from an ‘‘Iceman Motor Hose’’ kit sold by DJO UK Ltd
(Guildford, Surrey, UK). Speciﬁcally, the premade kit allows for a
well-maintained temperature water solution to be continuously
perfused over the subject’s feet, which are wrapped in foot-shaped
pads that circulate water over the skin surface. We modulated the
kit by bifurcating the circulation route such that each foot was
stimulated by the same water bath solution. Two separate water
baths were used to generate each stimulus condition. The motor-
ized water coolers were kept in the scan console room as they were
not MR compatible. A 3-meter-long insulated perfusion tube direc-
ted the water ﬂow from the coolers to the foot pads placed on the
subject. Water was able to continuously circulate between the
pads and the coolers without any obstruction to the scan session.
Additionally, temperature levels of each water cooler were contin-
uously maintained throughout the scan session using thermome-
ters. An experimenter would place the foot-shaped circulation
pads over the subject’s feet in between each scan block to effec-
tively ramp the stimulus condition to the desired setting (ie, cool-
ing vs erythromelalgia-associated baseline).
We did not scan these ramp sessions because we needed to
speak with the subject on a frequent basis to ensure that the stim-
ulus condition was inducing an appropriate experience and that
the subject was awake and able to participate in the scan. Each
ramp session took approximately 3 minutes.
Phases of erythromelalgia baseline pain (BASE) were induced
with a warm solution (average temperature 35.5C, SE 0.72) that
was below the heat pain threshold deﬁned by QST (average tem-
perature 43C, SE 0). Phases of pain relief (COOL) were inducedty, each coloured block represents the temperature of water continuously perfusing
ool’’ (mean temperature = 13.9, SE = 0.86; dark gray). The bottom panel shows the
red at the beginning and end of the paradigm. Five-minute blocks of continuous
e repeated 3 times per scan session. Each scan was separated by approximately
hen the pain intensity and unpleasantness ratings were taken (verbal report, NRS).
Fig. 2. Photograph of the patient’s legs showing erythema up to the level of the mid
calf.
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0.86).
Brain activity was recorded during 3 5-minute blocks of each
BASE and COOL stimulus temperature using quantitative perfusion
functional imaging. Each stimulus block was an independent scan.
Because there was no reliable way to stimulus-lock the onset of the
subject’s perceptual change with the stimulus condition and the
ﬁrst acquisition volume, the scan was started only after the subject
verbally reported that the pain had ceased (numerical rating scale
[NRS] = 0; COOL) or was strong (NRS > 5; BASE). Each scan was ex-
actly 5 minutes long. Pain intensity ratings were monitored ver-
bally using an NRS (0 = no pain; 10 = worst pain) at the very
beginning and end of each stimulus block. Additionally, after each
COOL block, a pleasantness score (NRS: 0 = not pleasant; 10 = most
pleasant) was taken.
2.3. MR parameters
The subject was scanned with a pseudo-continuous ASL (pCASL)
sequence [11] using gradient-echo echo planar imaging readout
(repetition time = 3.75 seconds, echo time = 13 ms, full k-space).
Twenty-four axial slices in ascending order (3  3  4.5 mm vox-
els, 0.5 mm inter-slice gap) were prescribed for the subject, provid-
ing whole brain coverage (including brainstem and cerebellum).
The labelling plane was chosen optimally for the subject based
on a time-of-ﬂight scan of the neck, located 8–10 cm inferior to
the centre of the 26 slices. A 90 presaturation pulse was applied
before the labelling pulses. The labelling duration was 1.4 seconds
and 5 different post-labelling delay (PLD) times were adopted. The
5 PLD values (0.64 seconds, 0.792 seconds, 0.896 seconds, 1 sec-
onds, 1.152 seconds) were generated according to Optimal Sam-
pling Schedule theory [7,39]. PLD times were pseudo-randomised
per repetition time. The same order was applied to every subject;
16 PLD values were applied for each 2-minute stimulus block.
The subject was scanned using a Siemens 3T Verio system (Erlan-
gen, Germany) ﬁtted with a 32-channel head coil.
2.4. Image analysis
Imaging data were analysed using the FMRIB Software Library
[33]. All data were pre-processed using standard FMRIB Software
Library tools in native space.
At the ﬁrst level, data were preprocessed using MCFLIRT (mo-
tion correction [23]), BET (brain extraction [24]), spatially
smoothed (full width at half maximum = 5 mm) and high pass ﬁl-
tered (320 seconds). Data were de-noised of nonphysiological arte-
facts through visual inspection of independent components [26].
All analysis was carried out in native space. At the ﬁrst level, the
general linear model was adopted for modelling CBF and any con-
taminating BOLD effects. At the second level, a model of each stim-
ulus condition and relevant contrasts (eg, BASE > COOL) was ﬁt to
the subject’s perfusion time series using a ﬁxed-effects analysis.
At the top level, a ﬁxed-effects analysis was used to observe the
average CBF changes speciﬁc to each contrast (ie, BASE > COOL:
group mean CBF changes showing regions more active during pain
vs cooling). Cluster-based thresholding was used to generate clus-
ters of CBF changes showing effects with a signiﬁcance level of
P < 0.05, using a z-score cut-off of 2.3.
3. Results
3.1. Case report
The patient was assessed at the age of 29 years old. She pre-
sented at birth with erythema of the hands and feet and as soon
as she was able to talk complained of hot painful feet. Initiallyshe described ﬂuctuations of her symptoms with exacerbations
of pain and erythema triggered by warmth, exercise, alcohol, and
wearing enclosed shoes; her symptoms could be alleviated by cool-
ing. She had previously developed foot ulceration as a consequence
of excessive cooling in cold water and at the age of 16 years re-
ceived epidural anaesthesia to control her pain. She currently re-
ports constant foot pain. Her pain has partially responded to
topical 5% lidocaine plasters (applied to the feet for 12 hours a
day) and she had also derived some relief from treatment with
imipramine 100 mg daily. There is no family history of erythromel-
algia; her parents and brother are unaffected. On examination she
had erythema of the ﬁngers and feet extending up to the mid calf
(Fig. 2). Neurological examination was normal.
A full QST protocol [32] was conducted in accordance with the
German Research Network on Neuropathic Pain (Fig. 3). This dem-
onstrated hypersensitivity to noxious thermal stimuli applied to
the feet (her heat pain threshold was reduced by 3 SDs from the
mean of gender- and age-matched controls). Unexpectedly, she
had reduced sensitivity to pressure pain and vibration detection
in the feet, which may relate to trophic changes in the skin follow-
ing prolonged erythromelalgia.
3.2. Conﬁrmation of the Nav1.7 mutation
DNA sequence analysis revealed a heterozygous missense
mutation in SCN9A gene, which encodes Nav1.7 (a C to T substitu-
tion at 2572), resulting in the substitution of leucine 858 with
phenylalanine (L858F). This mutation has previously been de-
scribed in a Canadian and Chinese family and is associated with
a severe phenotype with an early onset of symptoms [13,18].
DNA sequence analysis of the parents was not performed, as nei-
ther was clinically affected, suggesting a de novo mutation. This
mutation has previously been shown to cause a hyperpolarizing
shift in channel activation [9,17] and an enhanced response to slow
depolarizations; cooling can shift the activation midpoint of L858F
in a depolarizing direction, bringing the threshold of activation of
the mutant channel closer to wild-type Nav1.7 [17]; this provides
a biophysical correlate of the relief of pain by cooling in patients
with this mutation.
3.3. Psychophysics
Fig. 4A shows the mean pain intensity ratings for the baseline
warming and cooling stimuli. The mean pain intensity rating for
Fig. 3. Quantitative sensory test results. Quantitative sensory tests were performed on both hands and feet. These same tests have been repeated in normal healthy controls
to comprise an extensive database as generated and held by the German Neuropathic Pain Network (DFNS) (8). These normal data are distributed within the shaded area
(mean at 0 ± 2 SDs). Data from our subject are reported as z-score proﬁles for each sensory test as depicted here. z Score is deﬁned as the SD of the recorded result from the
mean normal data result. Each data point is discrete, however, they are connected for graphical illustration as a z proﬁle. Quantitative sensory tests included: CDT (cold
detection threshold), WDT (warm detection threshold), TSL (thermal sensory limen), CPT (cold pain threshold), HPT (heat pain threshold), PPT (pressure pain threshold), MPT
(mechanical pain threshold), MPS (mechanical pain sensitivity), WUR (wind up ratio), MDT (medical detection threshold), and VDT (vibration detection threshold). All tests to
the control site were within normal limits. Hypersensitivity to heat pain is demonstrated by a lowered HPT in the feet. Hyposensitivity to deep pressure (PPT) and vibration
(VDT) is also seen in the feet. These abnormal sensitivities may be attributable to thickening of the skin at the test site. Additionally, the presence of paradoxical heat
sensations was tested using TSL. Three paradoxical heat sensations were recorded in the feet (an abnormally high number), whilst there were none in the hands.
Fig. 4. (A) Psychophysical data. Verbally reported pain intensity (solid) and unpleasantness (opaque) ratings averaged over the 5-minute blocks of erythromelalgia-associated
heat pain (purple) and blocks of pain relief (blue) across both sessions. Error bars represent SD from the mean. (B) Brain perfusion data from the erythromelalgia case study
acquired with the multi-TI whole brain pseudo-continuous arterial spin labelling sequence. Averaged zstat maps (n = 1) of perfusion activation superimposed on the MNI152
standard template brain (ﬁxed effects, cluster corrected; z: 2.3–5.0, P < 0.05). Perfusion maps represent the contrast of the subject’s erythromelalgia-associated pain vs blocks
of cooling pain relief. The sagittal slice shows the column of activation across the whole brain. Axial slices (one slice every 10 mm in ascending order) correspond to the plane
indicated in the sagittal slice.
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SE = 0.41). The mean pain unpleasantness rating during warming
was 5.75, SE = 0.41. During phases of cooling, the patient always
rated the pain intensity and unpleasantness as <1 (or, not painful).
There was a signiﬁcant difference in pain intensity (Student t-test,
P < 0.001) and unpleasantness (Student t-test, p < 0.001) across the
conditions. To note: the subject self-reported that her left foot was
always in more pain on each scan session. The subject consistently
rated every cooling block as very pleasant (8 out of 10).
3.4. Perfusion imaging data: pain contrast
Signiﬁcant changes in CBF generated by the contrast of Baseline
pain > Cooling relief are shown in Fig. 4B. Coloured regions repre-
sent voxels with suprathreshold t-statistics generated from the
FEAT analysis of variance across sessions. Signiﬁcant increases in
CBF occurred in many regions shown previously to be involvedin processing acute [2], phasic [31], and tonic [19,29,30] pain. Ac-
tive regions include: bilateral thalamus, primary somatosensory
cortex (S1), inferior frontal gyrus, anterior, mid and posterior cin-
gulate, right caudate, right putamen, and the left anterior insula.
No signiﬁcant changes in CBF were observed in the reverse con-
trast of Cooling relief > Baseline pain. All coordinates are in Mon-
treal Neurological Institute space.
4. Discussion
In this study we have used a composite diagnostic experimental
approach incorporating QST, genetic sequencing, and perfusion
imaging to study a patient presenting with pain and erythema of
the extremities. Genetic testing showed that these symptoms were
due to the painful channelopathy IEM (due to a L858F Nav1.7
mutation). QST demonstrated hypersensitivity to heat and
conﬁrmed the temperature dependence of her tonic pain. Finally,
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neural correlates of the patient’s pain vs phases of cooling relief.
This patient has a severe form of IEM; shewas noted to have ery-
thematous feet at birth and although onset of this disorder has pre-
viously been described as early as 1–2 years of age, we have not
seen any previous reports of congenital onset [14]. She has always
complained of bilateral foot pain exacerbated by warmth and re-
lieved by cooling. Initially her symptoms were episodic, however,
from her second decade she developed constant foot pain at room
temperature that could only be relieved by cooling. IEM occurs as
a consequence of gain of function mutations in the voltage-gated
sodium channel Nav1.7 [13,14,20]. The patient described here was
found to have a substitution of the amino acid phenylalanine for
leucine at codon 858 of Nav1.7. This is within the S4/5 linker of do-
main 2 of the channel. This mutation has previously been described
and is associated with a severe erythromelalgia phenotype with a
young age of onset in a Canadian [13] and a Chinese kindred [18].
Nav1.7 mutations causing IEM are highly penetrant and give
rise to increased dorsal root ganglion cell hyperexcitability (and
hence pain) via a number of alterations in channel function, includ-
ing: a hyperpolarizing shift in channel activation, slowed deactiva-
tion, and an enhanced response to slow ramp-like stimuli (ramp
currents) [14]. Particular mutations have distinct effects on chan-
nel function and there is a complex relationship between these
changes and the clinical severity: the greater the hyperpolarizing
shift in activation, the earlier the age of onset [20]. However, muta-
tions that also enhance slow inactivation reduce channel availabil-
ity and lead to a milder phenotype [17]. The L858F mutation
present in our patient has been reported to cause a large hyperpo-
larizing shift in voltage-dependent activation with no effect on
slow inactivation. These biophysical changes therefore correlate
with the severe phenotype [9,16]. Interestingly, cooling has been
shown to shift the activation midpoint of L858F in a depolarizing
direction, bringing the threshold of activation of the mutant chan-
nel closer to wild-type Nav1.7 [17]. The patient reported here dem-
onstrated noxious heat hypersensitivity on QST of the feet, and the
level of her tonic pain was strongly modulated by ambient temper-
ature (being rapidly relieved by cooling). We exploited this phe-
nomenon to investigate the imaging correlates of her tonic pain.
The patient showed robust activation of key pain sensory and
pain-affect regions during phases of IEM-related pain that ceased
during cooling relief. Pain was related to increased perfusion in
the bilateral thalamus, S1, inferior frontal gyrus, anterior, mid and
posterior cingulate, right putamen, right caudate, and the left ante-
rior insula. There was a lateral dominance of activity in several re-
gions that was contralateral to her greatest foot pain, as would be
expected. Our data align with previous tonic pain studies using
ASL and positron emission tomography. For example, regions such
as the insula, thalamus, putamen, cingulate, and S1 have all been
shown previously to play a role in ongoing pain states. While the
present study is unable to interrogate the mechanisms of tonic pain
processing, these data provide exciting additional evidence that
many regions activated in well-known BOLD fMRI studies of acute
pain are also found to be active during a chronic pain state [20,21].
Because of the robust relieving action induced by cooling at the
site of the erythromelalgia pain, it was possible to image the atten-
uation of brain regions constituent of a multidimensional pain net-
work. Cooling relief caused a cessation of activation in these
regions. No additional regions were observed to be more active
during cooling compared to pain. While this could be due to low
signal-to-noise related to the single-subject nature of the case, it
is clear that the cooling stimulus acting at the site of the erythema
is a major component driving pain relief. This would be consistent
with the effects of cooling on mutant L858P Nav1.7 function and
presumably correlates with reduced ongoing nociceptor activity
following cooling. Microneurography has been performed in acohort of patients with primary erythromelalgia, and this demon-
strated altered C-ﬁbre function, including enhanced activity-
dependent slowing of afferent units and increased spontaneous
activity [28]. The effects of cooling on C-ﬁbre function were not
investigated in this report.
Interestingly, pain relief in the form of cessation or reduction of
a noxious stimulus can be thought of as a reward. Occasionally, this
sensation is pleasurable. Previous work by Becerra et al. (2001,
2006) and Baliki et al. (2010) provide strong evidence that activity
within the nucleus accumbens (NAc) tracks phases of pleasurable
relief related to pain offset [3–5]. Similarly, because of the block
design used in the current study, we predict that increased activa-
tion within the NAc during phases of cooling would be visible as
the cooling blocks reﬂect a kind of pleasurable pain-offset trig-
gered by reduced nociceptor function. While the present investiga-
tion was unable to observe signiﬁcant perfusion changes from a
whole-brain analysis during cooling relief; it is possible that subse-
quent investigations focused purely on the NAc may provide in-
sight into the higher cognitive processes underlying the
experience of pleasure related to cooling-induced relief of erythro-
melalgia-associated pain.
The present study conﬁrms the temperature dependence of the
L858F Nav1.7 mutation and further demonstrates the related ef-
fects on pain processing in the cortex by using a pCASL fMRI ap-
proach. Recent advances in ASL pulse sequence programming
have improved the technique such that pCASL beneﬁts from
greatly enhanced signal-to-noise ratio and reproducibility com-
pared to other commonly used ASL approaches [8,15]. However,
it is possible that the technique is still ill suited to do single-subject
investigations without the capacity to do multiple repeat scans
within the subject, as we have done here. Follow-up studies may
further beneﬁt by deﬁning a priori hypotheses about speciﬁc brain
regions of interest such that more region-of-interest-driven analy-
ses may be used that do not necessitate whole-brain corrections.
A key goal of this work was to employ a composite investigative
approach to study a chronic pain condition. From previous pain
neuroimaging studies, it is well known that pain is a complex, sub-
jective experience constituent of sensory, psychological, cognitive
and neuropharmacological factors. This is made even more com-
plex in the context of chronic pain, where unique combinations
of structural and functional abnormalities could possibly be used
to deﬁne different types of pain disease states [36]. The success
of future human pain studies relies partly on the capacity to encap-
sulate this complexity. As a case study, the present work attempted
to do this by employing a multivariate investigative approach that
interrogated the pain from the level of ion channel dysfunction on
peripheral nociceptors to higher cortical pain processing in the
brain. Interpreting the brain imaging data, although in a single sub-
ject, it is clear that the optimised ASL approach used is capable of
imaging the effect of chronic pain and relief across a whole brain.
Additionally, our data provide evidence that in the case of erythro-
melalgia, it appears as though cooling relief produces analgesia via
attenuation of peripheral inputs rather than via top-down brain
mechanisms related to pleasant relief.
We hope that future studies employing a composite, ‘‘molecule-
to-man’’ approach as we have done here will help develop a mech-
anism-based understanding of chronic pain in patients.
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